Pediatric Dermatology

Ulerythema Ophryogenes: Updates and Insights

Author and Disclosure Information

Ulerythema ophryogenes is a rare cutaneous atrophic disorder that occasionally is associated with Noonan syndrome, de Lange syndrome, Rubinstein-Taybi syndrome, and cardiofaciocutaneous (CFC) syndrome. Often presenting in pediatric patients, the pathogenesis of ulerythema ophryogenes remains unclear, though several genetic causes have been suggested. Treatment recommendations remain anecdotal, but clearance has been noted as the patient ages. Although topical agents have been the mainstay of therapy, recent advancement in laser intervention for treatment of ulerythema ophryogenes is promising.

Test your knowledge on ulerythema ophryogenes with MD-IQ: the medical intelligence quiz. Click here to answer 5 questions.


 

Recommended Reading

FDA updates clobazam label to reflect risk of severe skin reactions
MDedge Dermatology
Lichen Nitidus
MDedge Dermatology
Pediatric Halo Scalp Ring
MDedge Dermatology
Caring for Neonatal Skin
MDedge Dermatology
Misdiagnosis, noncompliance often culprits in refractory celiac disease
MDedge Dermatology
Molluscum Contagiosum Clears Atopic Dermatitis: A Case Report
MDedge Dermatology
Melanoma Screening in Children
MDedge Dermatology
Gene panel identifies residual neuroblastoma metastases
MDedge Dermatology
Substantial drop in rate of NICU candidiasis
MDedge Dermatology
For trichotillomania, try behavioral therapy before drugs
MDedge Dermatology

Related Articles